TradingViewTradingView

Kewaunee reports Q1 FY2027: Sales $66.32M, Net earnings $1.706M, Diluted EPS $0.58

1 minuto di lettura

Kewaunee on September 9, 2026 reported results for the first quarter of fiscal 2027 with net sales of $66.32 million and net earnings attributable to Kewaunee of $1.706 million (diluted EPS $0.58). Pre-tax earnings declined to $2.56 million and consolidated EBITDA was $4.525 million for the quarter. The company noted backlog increased to $169.0 million and highlighted improved international segment profitability despite lower sales.

Financial Highlights

  • Net sales: $66,320,000 for the three months ended July 31, 2026 (down 6.7% year-over-year).
  • Gross profit: $19,639,000 (as reported for the quarter).
  • Operating profit: $3,158,000 for the quarter ended July 31, 2026.
  • Pre-tax earnings: $2,560,000 for the quarter; Net earnings attributable to Kewaunee: $1,706,000.
  • Diluted earnings per share: $0.58; Consolidated EBITDA: $4,525,000 for the quarter.

Business Highlights

  • Backlog increased to $169.0 million on July 31, 2026, up from $165.9 million on April 30, 2026 (compared with $205.0 million on July 31, 2025).
  • Lab Products Group (LPG) segment: sales of $50.868 million (down 6.4% year-over-year); segment maintained solid profitability supported by stronger education market, cost management, and operating efficiencies.
  • International segment: sales of $15.452 million (down 7.8% year-over-year) with segment net earnings up 23.5% and segment EBITDA up 13.9% driven by a favorable mix of higher-margin projects.
  • Corporate actions: recorded additional compensation expense related to settling specific long-term incentive awards in cash to reduce shareholder dilution; company expects this incremental expense to be non-recurring.
  • Balance sheet and liquidity: total cash on hand $10.261 million; long-term debt net of the December 2021 sale-leaseback was $13.844 million; debt-to-equity ratio 0.59-to-1 (0.25-to-1 net of sale-leaseback).

Original SEC Filing: KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ] - 8-K - Sep. 09, 2026

Declinazione di responsabilità